DNA Vaccines: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary

Chapter 3 Market Overview

Introduction
DNA Vaccine Technologies Covered in This Report

• Global Market for DNA Vaccines
• Forces Driving DNA Vaccine Market Growth
• Life Cycle Status of DNA Vaccine Technologies
• Commercial Status of DNA Vaccine Technologies
• DNA Vaccine Industry

Chapter 4 DNA Vaccine Technologies

Introduction
Human Immune System
Vaccines

• Evolution of Vaccines
• Types of Vaccines

DNA Vaccines

• Changing Vaccine Paradigm

Function and Scope of DNA Vaccines
Cancer DNA Vaccines

• DNA Vaccine Technology Value Chain
• Antigen Discovery
• Plasmid Design
• Plasmid Manufacture
• Delivery Technologies
• Uncomplexed pDNA
• Electroporation
• Liposomes
• Gold Particles
• Nanoparticles
• Bacterial Ghosts
• Bacteriophages
• Viruses
• Targeting Technologies
• Adjuvant Technologies
• DNA Vaccine Technology Needs

Chapter 5 DNA Vaccine Applications

Research Tool Applications
Clinical Application

• Overview to DNA Vaccine Clinical Trials Process
• Summary of DNA Vaccine Clinical Trials

Chapter 6 DNA Vaccine Industry

Vaccine Industry Structural Shifts

• Industry Structure
• DNA Vaccine Industry Competitors
• DNA Vaccine Commercial Value Chain
• DNA Vaccine Competitor Strategic Positioning

Research & Development

Chapter 7 DNA Vaccine Markets

Drivers of Growth
DNA Vaccine Markets

• Market Forecasts
• DNA Vaccine Research Tool Markets
• DNA Vaccine Clinical Markets

DNA Vaccine Market by Region

• Research Tools for DNA Vaccine Market by Region
• Clinical DNA Vaccine Market by Region

Chapter 8 Impact of COVID-19

Vaccines, Treatments and Diagnostics

• Vaccines
• Therapeutics

Economic Impact of COVID-19

Chapter 9 Company Profiles

ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO.
GILEAD SCIENCES INC.
JOHNSON & JOHNSON
MERCK & CO.
NOVARTIS AG
PFIZER INC.
SANOFI-AVENTIS

List of Tables

Summary Table : Global DNA Vaccine Market, by Type, Through 2026
Table A : Scope of Report
Table 1 : Growth Drivers of DNA Vaccine Industry
Table 2 : Life Cycle Stage of Vaccine Types
Table 3 : Commercial Status of DNA Vaccines
Table 4 : DNA Vaccines Industry Structure
Table 5 : DNA Vaccine History
Table 6 : Components of the Immune System
Table 7 : Vaccine Types
Table 8 : Technology Life Cycle Stage of Vaccine Types
Table 9 : Changing Vaccine Production
Table 10 : Advantages and Disadvantages of DNA Vaccines
Table 11 : Emerging Competitive Landscape for DNA Vaccines
Table 12 : Cancer Vaccine Types
Table 13 : Technology Drivers for DNA Vaccine Value Chain
Table 14 : Plasmid Design Objectives
Table 15 : Ways to Optimize Mammalian Gene Expression in Plasmid DNA
Table 16 : DNA Plasmid Quality Comparison
Table 17 : Comparison of DNA Delivery Technologies
Table 18 : Comparison of In Vivo Viral Vector Technologies
Table 19 : DNA Vaccine Adjuvant Technologies
Table 20 : Technology Needs for DNA Vaccines
Table 21 : DNA Vaccine Development
Table 22 : DNA Vaccine Preclinical Development Steps
Table 23 : Summary of DNA Vaccine Clinical Phase I Trials, June 2021
Table 24 : Summary of DNA Vaccine Clinical Phase II Trials, June 2021
Table 25 : Summary of DNA Vaccine Clinical Phase III Trials, June 2021
Table 26 : Summary of DNA Vaccine Clinical Phase IV Trials, June 2021
Table 27 : Summary of DNA Vaccine Cancer Clinical Trials, June 2021
Table 28 : Infectious Disease DNA Vaccine Clinical Trials, June 2021
Table 29 : Comparison of the Regulation of Rare Diseases and Orphan Drugs Worldwide
Table 30 : Structural Shifts in Vaccine Industry
Table 31 : Vaccine Industry Structure: Traditional Vs. Emerging
Table 32 : Comparison of Vaccines and Drugs
Table 33 : DNA Vaccine Industry Competitors
Table 34 : Large Pharma Vaccine Company Strategic Focus
Table 35 : Integrated Biotechnology Company Strategic Focus
Table 36 : Strategy Market Focus of Integrated Biotechnology Companies
Table 37 : Strategic Focus of Specialized Biotechnology Companies
Table 38 : Astellas Pharma Inc. Open Clinical Trials, June 2021
Table 39 : Bavarian Nordic Open Clinical Trials, June 2021
Table 40 : City of Hope Medical Center, National Cancer Institute (NCI) Open Clinical Trials, June 2021
Table 41 : Glaxosmithkline Open Clinical Trials, June 2021
Table 42 : Imperial College London Open Clinical Trials, June 2021
Table 43 : Merck Sharp & Dohme Open Clinical Trials, June 2021
Table 44 : National Institute of Allergy and Infectious Diseases (NIAID) Open Clinical Trials, June 2021
Table 45 : National Taiwan University Hospital Open Clinical Trials, June 2021
Table 46 : Sanofi Open Clinical Trials, June 2021
Table 47 : Sidney Kimmel Comprehensive Cancer Center Open Clinical Trials, June 2021
Table 48 : U.S. Army Medical Research Open Clinical Trials, June 2021
Table 49 : University of Colorado Open Clinical Trials, June 2021
Table 50 : University of Oxford Open Clinical Trials, June 2021
Table 51 : Driving Forces of the DNA Vaccine Industry’s Growth
Table 52 : Global Market for DNA Vaccines, by Type, Through 2026
Table 53 : Global Market for DNA Vaccine Research Tools, by Application, Through 2026
Table 54 : Global Market for Clinical DNA Vaccines, by End Use, Through 2026
Table 55 : DNA Vaccine Allergy Market Opportunities
Table 56 : Cause of Death, Worldwide, 2019 and 2030
Table 57 : Global Market for Cancer Clinical DNA Vaccines, by Indication, Through 2026
Table 58 : DNA Vaccine Cancer Market Opportunities
Table 59 : Global Market for Infectious Disease Clinical DNA Vaccines, by Type, Through 2026
Table 60 : Global Market for Animal Health Clinical DNA Vaccines, by Indication, Through 2026
Table 61 : Global Market for Biodefense Clinical DNA Vaccines, by End User, Through 2026
Table 62 : Global Market for Clinical DNA Vaccines, by Delivery Technology, Through 2026
Table 63 : Global Market for Clinical DNA Vaccines, by Vaccine Format, Through 2026
Table 64 : Global Market for Clinical DNA Vaccines, by Vaccine Function, Through 2026
Table 65 : Global Market for DNA Vaccines, by Region, Through 2026
Table 66 : Global Market for Research Tools for DNA Vaccines, by Region, Through 2026
Table 67 : Global Market for Clinical DNA Vaccines, by Region, Through 2026
Table 68 : COVID-19 Global Impact on Public Health (as of June 2021)

List of Figures

Summary Figure : Global DNA Vaccine Market, by Type, 2019-2026
Figure 1 : Evolution of Vaccine Technologies
Figure 2 : Mechanism of Action of a DNA Vaccine
Figure 3 : Safety and Efficacy Profile of DNA Vs. Viral-Vector Vaccines
Figure 4 : DNA Vaccine Function and Market Scope
Figure 5 : DNA Vaccine Technology Value Chain
Figure 6 : Conventional and Plasmid DNA Vaccine Production Process
Figure 7 : Schematic of EP Process
Figure 8 : Strategies for Targeting Dendritic Cells
Figure 9 : Overview of Future Vaccine Clinical Trials
Figure 10 : Summary of DNA Vaccine Clinical Trials
Figure 11 : DNA Vaccine Clinical Phases from 2005 to 2021
Figure 12 : DNA Vaccine Commercial Value Chain
Figure 13 : DNA Vaccine Strategic Market Grid
Figure 14 : Pipeline of COVID-19 Vaccines, by R&D Stage
Figure 15 : Pipeline of COVID-19 Therapeutics, by R&D Stage
Figure 16 : Estimates of Economic Impact of COVID 19 and Recovery Forecasts

当レポートのプレスリリースは発行されておりません。